Linked Life Data

18788409

Source:http://linkedlifedata.com/resource/pubmed/id/18788409

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2008-9-15
pubmed:abstractText
It is suggested that hyperuricemia has a pathogenetical role in the onset and progression of hypertension and renal disease in both clinical studies and animal experiments. The treatment of hyperuricemia by allopurinol was reported to cause improvement of hypertension and renal function, and the withdrawal of allopurinol treatment was also reported to bring worsening of hypertension and acceleration of the rate of loss of renal function in the patients with chronic kidney disease (CKD). However, the necessity of treatment against hyperuricemia in CKD has to be warranted by large scale clinical experiments in the future.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0047-1852
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1779-85
pubmed:dateRevised
2011-7-27
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Measures against hyperuricemia].
pubmed:affiliation
Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine.
pubmed:publicationType
Journal Article, English Abstract, Review